Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques

BACKGROUND. The identification of patients with high-risk atherosclerotic plaques prior to the manifestation of clinical events remains challenging. Recent findings question histology- and imaging-based definitions of the “vulnerable plaque,” necessitating an improved approach for predicting onset o...

Descripción completa

Detalles Bibliográficos
Autores principales: Langley, Sarah R., Willeit, Karin, Didangelos, Athanasios, Matic, Ljubica Perisic, Skroblin, Philipp, Barallobre-Barreiro, Javier, Lengquist, Mariette, Rungger, Gregor, Kapustin, Alexander, Kedenko, Ludmilla, Molenaar, Chris, Lu, Ruifang, Barwari, Temo, Suna, Gonca, Yin, Xiaoke, Iglseder, Bernhard, Paulweber, Bernhard, Willeit, Peter, Shalhoub, Joseph, Pasterkamp, Gerard, Davies, Alun H., Monaco, Claudia, Hedin, Ulf, Shanahan, Catherine M., Willeit, Johann, Kiechl, Stefan, Mayr, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2017
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373893/
https://www.ncbi.nlm.nih.gov/pubmed/28319050
http://dx.doi.org/10.1172/JCI86924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373893/
https://www.ncbi.nlm.nih.gov/pubmed/28319050
http://dx.doi.org/10.1172/JCI86924

Ejemplares similares